10x Genomics (TXG) Change in Inventory (2018 - 2026)

10x Genomics has disclosed Change in Inventory across 9 years of filings, most recently posting -$2.7 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at -$2.7 million, up 66.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.6 million (down 174.97% YoY), and the FY2025 annual result was -$28.0 million, down 385.91% from the prior year.
• Change in Inventory came in at -$2.7 million for Q1 2026 at 10x Genomics, up from -$5.6 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $9.9 million in Q1 2024 to a low of -$9.6 million in Q4 2024.
• The 5-year median for Change in Inventory is $449000.0 (2023), against an average of -$444529.4.
• Across the five-year window, Change in Inventory sank 632.08% in 2023 and surged 2113.14% in 2024, its largest moves.
• 10x Genomics' Change in Inventory stood at $1.4 million in 2022, then tumbled by 632.08% to -$7.6 million in 2023, then dropped by 26.33% to -$9.6 million in 2024, then jumped by 41.97% to -$5.6 million in 2025, then soared by 51.59% to -$2.7 million in 2026.
• The last three Change in Inventory figures came in at -$2.7 million (Q1 2026), -$5.6 million (Q4 2025), and -$7.3 million (Q3 2025), per Business Quant data.